Jang G, Park R, Esteva E, Hsu P, Feng J, Upadhaya S
J Exp Med. 2025; 222(6).
PMID: 40072317
PMC: 11899982.
DOI: 10.1084/jem.20240587.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F
Nature. 2025; .
PMID: 40044861
DOI: 10.1038/s41586-025-08671-2.
Kim E, Kim E, Knott E, Wang Y, Chen C, Conejo-Garcia J
Sci Rep. 2025; 15(1):7127.
PMID: 40021683
PMC: 11871348.
DOI: 10.1038/s41598-025-90344-1.
Muller M, May S, Hall H, Kendall T, McGarry L, Blukacz L
Nature. 2025; .
PMID: 39972137
DOI: 10.1038/s41586-025-08585-z.
Schneider A, Koppe C, Crouchet E, Papargyriou A, Singer M, Buttner V
Nat Commun. 2025; 16(1):1765.
PMID: 39971907
PMC: 11839950.
DOI: 10.1038/s41467-025-56493-7.
Combinatorial In Vivo Genome Editing Identifies Widespread Epistasis and an Accessible Fitness Landscape During Lung Tumorigenesis.
Hebert J, Tang Y, Szamecz M, Andrejka L, Lopez S, Petrov D
Mol Biol Evol. 2025; 42(2).
PMID: 39907430
PMC: 11824425.
DOI: 10.1093/molbev/msaf023.
From bench to bedside: murine models of inherited and sporadic brain arteriovenous malformations.
Ricciardelli A, Genet G, Genet N, McClugage 3rd S, Kan P, Hirschi K
Angiogenesis. 2025; 28(2):15.
PMID: 39899215
PMC: 11790818.
DOI: 10.1007/s10456-024-09953-5.
Development of animal models to study aggressive thyroid cancers.
Dutta S, Knauf J
Eur Thyroid J. 2025; 14(1).
PMID: 39874138
PMC: 11825169.
DOI: 10.1530/ETJ-24-0361.
Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRAS oncogene-expressing tumor cells.
Hrckulak D, Onhajzer J, Krausova M, Stastna M, Kriz V, Janeckova L
Transgenic Res. 2025; 34(1):9.
PMID: 39786607
PMC: 11717838.
DOI: 10.1007/s11248-024-00429-2.
KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling.
Lasse-Opsahl E, Barravecchia I, McLintock E, Lee J, Ferris S, Espinoza C
JCI Insight. 2025; 10(1.
PMID: 39782689
PMC: 11721295.
DOI: 10.1172/jci.insight.182228.
Crypt density and recruited enhancers underlie intestinal tumour initiation.
Gaynor L, Singh H, Tie G, Badarinath K, Madha S, Mancini A
Nature. 2025; .
PMID: 39778708
DOI: 10.1038/s41586-024-08573-9.
Bispecific antibody targeting of lipid nanoparticles.
Amabile A, Phelan M, Yu Z, Silva P, Marks A, Morla-Folch J
bioRxiv. 2025; .
PMID: 39763831
PMC: 11702604.
DOI: 10.1101/2024.12.20.629467.
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.
Tomanelli M, Guffanti F, Vargiu G, Micotti E, Rigamonti M, Tumiatti F
Front Oncol. 2025; 14:1504938.
PMID: 39763604
PMC: 11701213.
DOI: 10.3389/fonc.2024.1504938.
The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice.
Sun J, Luo D, Li H, Zhang D, Liu Y, Jin S
Can Respir J. 2024; 2024:8827810.
PMID: 39735556
PMC: 11671638.
DOI: 10.1155/carj/8827810.
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models.
Li D, Geng K, Hao Y, Gu J, Kumar S, Olson A
J Clin Invest. 2024; 135(2.
PMID: 39718828
PMC: 11735103.
DOI: 10.1172/JCI174249.
Diet therapy abates mutant APC and KRas effects by reshaping plasma membrane cholesterol nanodomains.
Kim E, Erazo-Oliveras A, Munoz-Vega M, Fuentes N, Salinas M, George M
Biophys J. 2024; 124(3):508-527.
PMID: 39709523
PMC: 11866957.
DOI: 10.1016/j.bpj.2024.12.020.
A STAG2-PAXIP1/PAGR1 axis suppresses lung tumorigenesis.
Ashkin E, Tang Y, Xu H, Hung K, Belk J, Cai H
J Exp Med. 2024; 222(1).
PMID: 39652422
PMC: 11627241.
DOI: 10.1084/jem.20240765.
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis.
Zhuang X, Wang Q, Joost S, Ferrena A, Humphreys D, Li Z
Nature. 2024; 637(8044):184-194.
PMID: 39633048
DOI: 10.1038/s41586-024-08285-0.
Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state.
Rominger M, Gupta S, Moorthi S, McSharry M, Kamlapurkar S, OBrien S
bioRxiv. 2024; .
PMID: 39605726
PMC: 11601272.
DOI: 10.1101/2024.11.11.623044.
CRIPTO's multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient data.
Rodrigues Sousa E, de Brot S, Zoni E, Zeinali S, Brunello A, Scarpa M
Oncogene. 2024; 44(7):462-475.
PMID: 39592836
PMC: 11810784.
DOI: 10.1038/s41388-024-03230-x.